Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Dermatology
    • Drugs and sunshine:...

    Drugs and sunshine: Drugs that cause skin reactions upon sun exposure

    Written by Medha Baranwal Baranwal Published On 2019-08-07T19:28:48+05:30  |  Updated On 7 Aug 2019 7:28 PM IST
    Drugs and sunshine: Drugs that cause skin reactions upon sun exposure

    Photosensitivity, sometimes also referred to as sun allergy, is the reaction of the immune system triggered by sunlight. It includes severe sunburn, burning and itching sensations, redness, swelling, blistering, and more. reactions occur on areas of the body exposed to the sun, such as the face, the “V” of the neck, forearms, and hands.


    A drug is considered photoactive only if it causes a reaction with exposure to ultraviolet (UV) or visible light. Photosensitivity caused by oral drugs may be more prevalent than known because these reactions may be misdiagnosed or simply not reported. The following drugs are known to produce such photosensitive skin reactions.


    Amiodarone


    It is an antiarrhythmic drug used for the prevention and treatment of ventricular arrhythmias. It is the most studies of all photosensitizing medications, with reports of photosensitive reactions ranging from 14% to more than 50% of patients taking the drug. Photosensitivity typically presents as a burning and tingling sensation with associated reddening of sun-exposed skin. About 1% to 2% of patients develop a distinctive blue-grey pigmentation on sun-exposed areas, particularly after long-term exposure. Photosensitivity usually resolves in a few months after discontinuation of the drug, while the photo-induced pigmentation slowly fades over 1 to 2 years.


    Chlorpromazine


    Chlorpromazine, more commonly known by the brand name Thorazine, is an antipsychotic drug used to treat adults with schizophrenia or bipolar disorder. It’s also used to treat nausea, vomiting, and intractable hiccups. Patients taking chlorpromazine can experience an exaggerated sunburn reaction and sometimes blisters and lichenoid skin eruptions. Long-term, high-dose chlorpromazine therapy can result in slate-grey to violet hyperpigmentation of sun-exposed skin. Of note, parenterally administered antipsychotics have caused photo contact dermatitis in nurses administering the medication.


    Ciprofloxacin


    Ciprofloxacin, like other fluoroquinolone antibiotics, is well known to cause photosensitive reactions, with sunburn-like redness and inflammation when mild, and painful blistering and peeling when severe. In one rare case, the authors reported a patient with photoinduced purpura due to ciprofloxacin. In addition, patients with cystic fibrosis may have particular photosensitivity to the drug.


    Doxycycline


    Like the fluoroquinolones, the tetracyclines are another class of antibiotics highly recognized for photosensitive skin reactions. Doxycycline, in particular, is known to cause phototoxic conditions. And the higher the dose, the stronger the reaction. For instance, researchers showed that doxycycline at doses of 100 mg, 150 mg, and 200 mg resulted in phototoxicity reactions at rates of 3%, 20%, and 42%, respectively. The typical reaction is sunburn-like burning and reddening of sun-exposed skin; symptoms usually resolve within 10 to 14 days after discontinuation of the drug. Another uncommon but possible phototoxic reaction to doxycycline is onycholysis.


    Hydrochlorothiazide


    More than other thiazide diuretics, hydrochlorothiazide (HCTZ) has been associated with a variety of photosensitive reactions, including heightened sunburn, dermatitis, and lichenoid eruption. In some cases, chronic eczema can last months to years after discontinuing the drug. However, treatment is possible. In one study, for example, researchers reported successfully using psoralen in combination with UVA radiation (PUVA therapy) to treat patients who had developed chronic eczematous photosensitivity after taking HCTZ.


    Isotretinoin


    Photosensitivity is listed as one of the adverse events for this retinoid acne medication, commonly known by its former brand name Accutane. But the evidence seems to disagree or is inconclusive at best. In one trial, investigators noted that retinoid drugs like isotretinoin have “phototoxic potential,” but they couldn’t demonstrate clinical or experimental evidence of isotretinoin photosensitivity. In a similar study, researchers found insignificant experimental evidence and no clinical evidence of photosensitive reactions from isotretinoin.


    Naproxen


    Researchers have published a few reports of photosensitive reactions due to nonsteroidal anti-inflammatory drugs (NSAIDs). Of the most common NSAIDs, naproxen appears to have the most photosensitive reactions, usually presenting as pseudoporphyria.


    Vemurafenib


    Marketed as Zelboraf, vemurafenib is a kinase inhibitor for treating unresectable or metastatic melanoma in patients with BRAF V600E mutation. It can, however, cause mild to severe photosensitive reactions on sun-exposed skin—including burning sensation, redness, and swelling—in as many as 33% to 55% of patients who take it, specifically from UVA radiation, according to some researchers. And reactions occur quickly, within 24 to 48 hours. Because discontinuing the medication isn’t a realistic option for cancer patients, researchers recommend they use a broad-spectrum sunscreen with high UVA photoprotection as well as wearing clothing that protects them from the sun.


    Voriconazole


    Voriconazole is a triazole antifungal used to treat serious fungal and yeast infections. It’s also known to cause common photosensitive reactions, occasionally presenting as cheilitis or pseudoporphyria. Many cases of photosensitivity have been reported in immunocompromised patients on long-term prophylactic voriconazole therapy, particularly for chronic granulomatous disease and organ transplantation. In one case series, five recipients of allogeneic hematopoietic cell transplants received initial misdiagnoses of chronic graft-versus-host disease. Although acute dermatitis usually resolves after discontinuing voriconazole, the photosensitive reaction can often appear months after starting therapy. Along those lines, in multiple studies, investigators have reported subsequent photoaging as well as squamous cell carcinoma and melanoma in the areas of skin where the photosensitive reactions occurred.


    So, one should try to stay out of the sun or wear sunscreen while taking these drugs.
    ChlorpromazineCiprofloxacindoxycyclinedrugsexposurehydrochlorothiazideimmune systemimmunocompromised patientsIsotretinoinMedical newsnaproxenphotoagingphotosensitivephotosensitivityphotosensitizing medicationsskinSkin reactionssun allergyultravioletUVVemurafenibVoriconazole

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok